Product Details
![Magmaris BRS Magmaris BRS](https://biotronik.cdn.mediamid.com/cdn_bio_pic/bio23816/14103/bio23816_553x368.jpg)
First Clinically Proven Resorbable Magnesium Scaffold
No definite or probable scaffold thrombosis was observed with Magmaris.4 Previous generations showed no scaffold thrombosis up to 36 months.4
![Resorption Graph Resorption Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio24192/25879/bio24192_553x368.jpg)
Fast Magnesium Resorption Time
~95 % of Magnesium resorbed at 12 months3
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio23850/25883/bio23850_553x368.jpg)
Compelling Safety Data2
The optimal combination of the strut design, electropolished smooth scaffold surface and biocompatible coating facilitate rapid endothelial coverage:
15 % better endothelialization at 28 days3,6
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio23852/25887/bio23852_553x368.jpg)
Robust Magnesium Backbone
Strong radial resistance:
No significant diameter change under increasing physiological pressure5
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio23879/25891/bio23879_553x368.jpg)
No recoil increase:
Conventional polymeric scaffold7 diameter decrease >20 % within 1st hour5
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio25507/25895/bio25507_553x368.jpg)
Metallic Scaffolds for Better Deliverability6
Magnesium allows for a smoother scaffold surface for:
- Better lesion crossing - up to 40 % lower lesion entry and crossing force5,6
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio25508/25899/bio25508_553x368.jpg)
- Better trackability in tortuous anatomy - 29 % less peak force5,6
![Graph Graph](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio25509/25903/bio25509_553x368.jpg)
The dual coated delivery system enables:
- Better pushability - 34 % more force transmitted from hub to tip5,6
![Magmaris rounded edges Magmaris rounded edges](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio23933/25911/bio23933_553x368.jpg)
Electropolishing Ensures Rounded Edges
Magmaris' smooth surface generates less resistance than the polymeric scaffold7
BIOSOLVE-I
- Prospective, multi-center, first-in-man trial testing DREAMS (Drug-Eluting Absorbable Magnesium Scaffold)
- Number of patients: 46
- Primary endpoint: TLF at 6 and 12 months
![Magmaris Image Magmaris Image](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio26792/26003/bio26792_344x246.jpg)
BIOSOLVE-II
- Prospective, multi-center, first-in-man trial to evaluate the safety and performance of Magmaris with a maximum of two de novo lesions in two separate coronary arteries
- Number of patients: 123
- In-segment LLL at 6 months
![Magmaris Image Magmaris Image](http://biotronik.cdn.mediamid.com/cdn_bio_pic/bio26793/26007/bio26793_344x246.jpg)
Technical Data
Scaffold | |
---|---|
Scaffold material | Proprietary Magnesium alloy |
Markers | Two tantalum markers at each end |
Active coating | BIOlute bioabsorbable Poly-L-Lactide (PLLA) eluting a limus drug |
Drug dose | 1.4 μg/mm2 |
Strut thickness/width | 150 μm/150 μm |
Maximum expandable diameter | Nominal Diameter +0.6 mm |
Delivery System | |
---|---|
Catheter type | Rapid exchange |
Recommended guide catheter | 6F (min. I.D. 0.070") |
Crossing profile | 1.5 mm |
Guide wire diameter | 0.014" |
Usable catheter length | 140 cm |
Balloon material | Semi-rystalline polymer |
Coating (distal shaft) | Dual coated |
Marker bands | Two swaged platinum-iridium markers |
Proximal shaft diameter | 2.0F |
Distal shaft diameter | 2.9F |
Nominal pressure (NP) | 10 atm |
Rated burst pressure (RBP) | 16 atm |
Compliance Chart
Balloon Diameter x Length (mm) | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nominal Pressure | atm8 | 10 | 10 | ||||||||||||||||
(NP) | ø (mm) | 3.00 | 3.54 | ||||||||||||||||
Rated Burst Pressure | atm8 | 16 | 16 | ||||||||||||||||
(RBP) | ø (mm) | 3.29 | 3.82 |
Ordering Information
Contact
![Magmaris Image](/sites/default/files/styles/site_width/public/migrated_images/bio24342_553x246.jpg?itok=8wNKfbc-)
1 Indication as per IFU
2 BIOSOLVE-II
3 Pre-clinical trial. BIOTRONIK data on file
4 PROGRESS, BIOSOLVE-I, BIOSOLVE-II
5 BIOTRONIK data on file
6 comapred to polymeric scaffold (Abbott Absorb)
7 Abbott Absorb
8 1 atm = 1.013 bar